These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer. Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170 [TBL] [Abstract][Full Text] [Related]
9. Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial. Hempling RE; Piver MS; Baker TR Am J Clin Oncol; 1995 Aug; 18(4):282-6. PubMed ID: 7625366 [TBL] [Abstract][Full Text] [Related]
10. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer. Greven K; Winter K; Underhill K; Fontenesci J; Cooper J; Burke T; Int J Radiat Oncol Biol Phys; 2004 May; 59(1):168-73. PubMed ID: 15093913 [TBL] [Abstract][Full Text] [Related]
11. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Susumu N; Sagae S; Udagawa Y; Niwa K; Kuramoto H; Satoh S; Kudo R; Gynecol Oncol; 2008 Jan; 108(1):226-33. PubMed ID: 17996926 [TBL] [Abstract][Full Text] [Related]
12. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma. Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025 [TBL] [Abstract][Full Text] [Related]
13. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58. Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263 [TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced and recurrent endometrial cancer with cisplatin, doxorubicin, and cyclophosphamide. Dunton CJ; Pfeifer SM; Braitman LE; Morgan MA; Carlson JA; Mikuta JJ Gynecol Oncol; 1991 May; 41(2):113-6. PubMed ID: 2050302 [TBL] [Abstract][Full Text] [Related]
15. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin. Piver MS; Eltabbakh GH; Hempling RE; Recio FO; Blumenson LE Gynecol Oncol; 1997 Nov; 67(2):141-6. PubMed ID: 9367697 [TBL] [Abstract][Full Text] [Related]
16. [Adjuvant chemotherapy with cyclophosphamide, adriamycin, and CDDP (CAP) for high risk endometrial cancer after complete surgery]. Tsunoda H; Nishida M; Arisawa Y; Sato T; Oki A; Nishide K; Ichikawa Y; Kubo T Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jan; 48(1):45-51. PubMed ID: 8576621 [TBL] [Abstract][Full Text] [Related]
17. A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. Conte PF; Bruzzone M; Chiara S; Sertoli MR; Daga MG; Rubagotti A; Conio A; Ruvolo M; Rosso R; Santi L J Clin Oncol; 1986 Jun; 4(6):965-71. PubMed ID: 3519886 [TBL] [Abstract][Full Text] [Related]
18. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial. Soper JT; Reisinger SA; Ashbury R; Jones E; Clarke-Pearson DL Gynecol Oncol; 2004 Oct; 95(1):95-100. PubMed ID: 15385116 [TBL] [Abstract][Full Text] [Related]
19. Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC). Price FV; Chambers SK; Carcangiu ML; Kohorn EI; Schwartz PE; Chambers JT Gynecol Oncol; 1993 Dec; 51(3):383-9. PubMed ID: 8112650 [TBL] [Abstract][Full Text] [Related]
20. Feasibility study of combination chemotherapy with paclitaxel, doxorubicin and cisplatin without prophylactic granulocyte colony-stimulating factor injection for intermediate-to-high risk or recurrent endometrial cancer. Nagao S; Nishikawa T; Hanaoka T; Kurosaki A; Iwasa N; Hasegawa K; Fujiwara K Jpn J Clin Oncol; 2014 Nov; 44(11):1040-4. PubMed ID: 25183770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]